SCHEMBL25252374

SCHEMBL25252374

Cc1ccc(S(=O)(=O)NN=C2CN(C(=O)O)C2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.52
F2 P00734 1/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
KDM4E B2RXH2 1/20 0.42
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21815402 0.89 ALDH1A1 (0.57) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL1250612 0.88 ALDH1A1 (0.53) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL1250614 0.88 ALDH1A1 (0.53) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL18824341 0.86 ALDH1A1 (0.62) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL17825333 0.85 ALDH1A1 (0.63) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL18397145 0.82 KMT2A (0.51) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL25410750 0.81 ALDH1A1 (0.48) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL25339246 0.81 ALDH1A1 (0.57) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL25412804 0.79 ALDH1A1 (0.47) ALDH1A1F2PRSS1PRSS2PRSS3
SCHEMBL18228346 0.78 ALDH1A1 (0.70) ALDH1A1F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11981661-B2 Heterocyclic compounds HOFFMANN-LA ROCHE INC. (US) 2024-05-14 US disclosed
EP-4208456-A1 HETEROCYCLIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2023-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11981661-B2 Heterocyclic compounds CBR3, BRIX1, CCNY ALDH1A1 1218/4885F2 174/4885PRSS1 3694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.